Wound complications in neoadjuvant versus adjuvant treatment of operable rectal cancer (ORC)

被引:1
|
作者
Li, I.
Stitt, L.
Whiston, F.
Alkhayyat, S. S.
Vincent, M. D.
机构
[1] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, London, ON, Canada
[3] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
[4] London Reg Canc Program, London, ON, Canada
关键词
D O I
10.1200/jco.2010.28.15_suppl.e14099
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14099
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Adjuvant and neoadjuvant treatment of rectal cancer
    Valentini, V
    Morganti, AG
    Gambacorta, MA
    [J]. TUMORI, 2002, : S22 - S27
  • [2] Adjuvant and neoadjuvant treatment of rectal cancer
    Freedman, GM
    Coia, LR
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (06) : 611 - 624
  • [3] Adjuvant or neoadjuvant therapy in the treatment of rectal cancer
    Santoro, M.
    Colosimo, A.
    Riccelli, R.
    Falcone, S.
    Ianni, R.
    Pingitore, D.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 149 - 149
  • [4] Phase 1 studies of 'Tomudex' (raltitrexed) with pelvic radiotherapy (RT) for adjuvant treatment in patients with operable rectal cancer (ORC) & recurrent/inoperable rectal cancer (IRC)
    Botwood, N
    James, R
    Vernon, C
    Purnell, C
    Price, P
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [5] Chemoradiation for Localized Rectal Cancer: Neoadjuvant Versus Adjuvant Approaches
    Blaszkowsky, Lawrence S.
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2005, 1 (01) : 51 - 57
  • [6] Neoadjuvant Versus Adjuvant Systemic Therapy for Operable Breast Cancer Equivalent Outcomes?
    Smith, Barbara L.
    [J]. ANNALS OF SURGERY, 2013, 257 (02) : 180 - 181
  • [7] Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?
    Moorcraft, Sing Yu
    Smyth, Elizabeth C.
    Cunningham, David
    [J]. GASTRIC CANCER, 2015, 18 (01) : 1 - 10
  • [8] Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?
    Sing Yu Moorcraft
    Elizabeth C. Smyth
    David Cunningham
    [J]. Gastric Cancer, 2015, 18 : 1 - 10
  • [9] Phase 1 studies of 'Tomudex' (raltitrexed) with pelvic radiotherapy (RT) for adjuvant treatment in patients (PT) with operable rectal cancer (ORC) & recurrent/inoperable rectal cancer (IRC).
    Botwood, N
    James, R
    Vernon, C
    Purnell, C
    Price, P
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 45 - 45
  • [10] NEOADJUVANT THERAPY IN TREATMENT OF RECTAL CANCER AND ITS COMPLICATIONS
    Latorre, R.
    Priego, P.
    Sanjuanbenito, A.
    Tovar, Ruiz J.
    Diez, M.
    Calero, P.
    Housari, G.
    Martinez, E.
    Fresneda, V
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 112 - 112